SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Deferred Costs, Noncurrent
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Deferred Costs, Noncurrent of $12.12 thousand as of 2025-12-31, per its 10-Q filed 2026-09-24.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2026-09-24
- 2025-12-31: Deferred Costs, Noncurrent $12.12K.
- 2025-09-30: Deferred Costs, Noncurrent $30.30K.
- 2025-06-30: Deferred Costs, Noncurrent $48.49K.
- 2025-03-31: Deferred Costs, Noncurrent $71.88K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2025-12-31 | $12.12K 10-Q · filed 2026-09-24 |
| 2025-09-30 | $30.30K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $48.49K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $71.88K 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |